NOVOSTE CORP /FL/
10-Q, EX-27, 2000-11-14
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Previous: NOVOSTE CORP /FL/, 10-Q, 2000-11-14
Next: ONYX PHARMACEUTICALS INC, 10-Q, 2000-11-14



<TABLE> <S> <C>


<ARTICLE>                     5

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                              DEC-31-2000
<PERIOD-START>                                 JAN-01-2000
<PERIOD-END>                                   SEP-30-2000
<CASH>                                          49,196,757
<SECURITIES>                                    21,730,604
<RECEIVABLES>                                    2,356,105
<ALLOWANCES>                                       150,000
<INVENTORY>                                      1,159,356
<CURRENT-ASSETS>                                74,888,045
<PP&E>                                           8,687,465
<DEPRECIATION>                                   3,336,695
<TOTAL-ASSETS>                                  84,377,866
<CURRENT-LIABILITIES>                            7,894,210
<BONDS>                                                  0
                                    0
                                              0
<COMMON>                                           160,680
<OTHER-SE>                                      76,322,976
<TOTAL-LIABILITY-AND-EQUITY>                    84,377,866
<SALES>                                          3,583,575
<TOTAL-REVENUES>                                 3,583,575
<CGS>                                            2,594,894
<TOTAL-COSTS>                                   26,773,995
<OTHER-EXPENSES>                                         0
<LOSS-PROVISION>                                         0
<INTEREST-EXPENSE>                              (2,752,457)
<INCOME-PRETAX>                                (23,032,857)
<INCOME-TAX>                                             0
<INCOME-CONTINUING>                            (23,032,857)
<DISCONTINUED>                                           0
<EXTRAORDINARY>                                          0
<CHANGES>                                                0
<NET-INCOME>                                   (23,032,857)
<EPS-BASIC>                                          (1.50)
<EPS-DILUTED>                                        (1.50)



</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission